Trexquant Investment’s Axonics, Inc. Common Stock AXNX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-43,684
Closed -$2.2M 1901
2023
Q2
$2.2M Sell
43,684
-3,474
-7% -$185K 0.06% 461
2023
Q1
$2.57M Buy
47,158
+3,455
+8% +$202K 0.07% 374
2022
Q4
$2.73M Buy
43,703
+33,758
+339% +$2.24M 0.08% 327
2022
Q3
$701K Buy
9,945
+6,415
+182% +$442K 0.02% 661
2022
Q2
$200K Buy
+3,530
New +$194K 0.01% 1359
2020
Q4
Sell
-7,943
Closed -$405K 1585
2020
Q3
$405K Sell
7,943
-6,989
-47% -$292K 0.03% 791
2020
Q2
$524K Buy
+14,932
New +$514K 0.04% 664

Other funds holding AXNX

Trexquant Investment's AXNX Position: Q3 2023 in Review

Trexquant Investment sold out of Axonics, Inc. Common Stock (AXNX) in Q3 2023, closing a stake of 43,684 shares — an estimated $2.2M sold.

Trexquant Investment first reported a position in AXNX in Q2 2020 and held it in 7 quarters. The position peaked at $2.73M in Q4 2022. 220 funds tracked by Wall St. Rank hold AXNX as of Q3 2023.

  • Trexquant Investment reported no remaining Axonics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • Trexquant Investment sold 43,684 Axonics, Inc. Common Stock shares in Q3 2023, an estimated $2.2M.
  • Trexquant Investment first reported a position in Axonics, Inc. Common Stock in Q2 2020 and held it in 7 quarters.
  • Trexquant Investment's Axonics, Inc. Common Stock position peaked at $2.73M in Q4 2022.
  • 220 funds tracked by Wall St. Rank held Axonics, Inc. Common Stock as of Q3 2023.

Based on Trexquant Investment's 13F filing for Q3 2023, filed 13 Nov 2023.